Compagno, Nicoḷ <br/><br/>
Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.  [electronic resource] 

 -  Haematologica  Jun 2014 
 - 1101-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2013.101261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Agammaglobulinemia--drug therapy<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Drug Substitution<br/>Female<br/>Humans<br/>Immunoglobulin G--blood<br/>Immunoglobulins--administration & dosage<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Immunologic Factors--adverse effects<br/>Infections--etiology<br/>Infusions, Subcutaneous<br/>Lymphoproliferative Disorders--complications<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Rituximab<br/>Treatment Outcome<br/>Young Adult